tetano
Editor, Senior Moderator
Int J Hyg Environ Health
. 2020 Nov 30;232:113671.
doi: 10.1016/j.ijheh.2020.113671. Online ahead of print.
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
Thomas Theo Brehm[SUP] 1 [/SUP], Dorothee Schwinge[SUP] 2 [/SUP], Sibylle Lampalzer[SUP] 2 [/SUP], Veronika Schlicker[SUP] 3 [/SUP], Julia K?chen[SUP] 2 [/SUP], Michelle Thompson[SUP] 2 [/SUP], Felix Ullrich[SUP] 2 [/SUP], Samuel Huber[SUP] 2 [/SUP], Stefan Schmiedel[SUP] 3 [/SUP], Marylyn M Addo[SUP] 3 [/SUP], Marc L?tgehetmann[SUP] 4 [/SUP], Johannes K Knobloch[SUP] 4 [/SUP], Julian Schulze Zur Wiesch[SUP] 3 [/SUP], Ansgar W Lohse[SUP] 3 [/SUP]
Affiliations
Abstract
We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n = 22), indicating the overall effectiveness of infection control interventions in mitigating coronavirus disease 2019 (COVID-19) in hospital workers.
Keywords: COVID-19; Germany; Healthcare workers; Hospital workers; SARS-CoV-2; Seroprevalence.
. 2020 Nov 30;232:113671.
doi: 10.1016/j.ijheh.2020.113671. Online ahead of print.
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
Thomas Theo Brehm[SUP] 1 [/SUP], Dorothee Schwinge[SUP] 2 [/SUP], Sibylle Lampalzer[SUP] 2 [/SUP], Veronika Schlicker[SUP] 3 [/SUP], Julia K?chen[SUP] 2 [/SUP], Michelle Thompson[SUP] 2 [/SUP], Felix Ullrich[SUP] 2 [/SUP], Samuel Huber[SUP] 2 [/SUP], Stefan Schmiedel[SUP] 3 [/SUP], Marylyn M Addo[SUP] 3 [/SUP], Marc L?tgehetmann[SUP] 4 [/SUP], Johannes K Knobloch[SUP] 4 [/SUP], Julian Schulze Zur Wiesch[SUP] 3 [/SUP], Ansgar W Lohse[SUP] 3 [/SUP]
Affiliations
- PMID: 33338782
- DOI: 10.1016/j.ijheh.2020.113671
Abstract
We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n = 22), indicating the overall effectiveness of infection control interventions in mitigating coronavirus disease 2019 (COVID-19) in hospital workers.
Keywords: COVID-19; Germany; Healthcare workers; Hospital workers; SARS-CoV-2; Seroprevalence.